Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT02303522 · COMPLETED

Trial details

NCT number: NCT02303522
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

Start date: 2014-12-09
Primary completion: 2015-01-22
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.